Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.
Metrics to compare | 002294 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002294PeersSector | |
|---|---|---|---|---|
P/E Ratio | 93.1x | 31.8x | −0.4x | |
PEG Ratio | 8.33 | 0.86 | 0.00 | |
Price / Book | 6.9x | 2.6x | 2.6x | |
Price / LTM Sales | 13.9x | 3.7x | 3.2x | |
Upside (Analyst Target) | 6.2% | 36.5% | 45.4% | |
Fair Value Upside | Unlock | 18.6% | 7.0% | Unlock |